Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery

Metabolism: Clinical and Experimental

Volumn 58, Issue 10, 2009, Pages 1400-1407

  Nakatani, Hiroshi ^a   Kasama, Kazunori ^b   Oshiro, Takashi ^b   Watanabe, Mitsuhiro ^a   Hirose, Hiroshi ^a,c   Itoh, Hiroshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Yotsuya Medicalcube Hospital   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE; GLYCOSYLATED HEMOGLOBIN; HORMONE; IMMUNOREACTIVE INSULIN; INCRETIN;

ADULT; ARTICLE; BARIATRIC SURGERY; BILE ACID BLOOD LEVEL; BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; FEMALE; HUMAN; INSULIN BLOOD LEVEL; LAPAROSCOPIC SURGERY; MALE; MOLECULAR WEIGHT; MORBID OBESITY; PRIORITY JOURNAL; WEIGHT REDUCTION;

ADIPOKINES; ADIPONECTIN; ADULT; BARIATRIC SURGERY; BILE ACIDS AND SALTS; BODY MASS INDEX; FEMALE; HUMANS; INCRETINS; LAPAROSCOPY; MALE; MIDDLE AGED; MOLECULAR WEIGHT; OBESITY, MORBID;

EID: 70149108533     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.05.006     Document Type: Article

References (27)

1. Sjostrom L., Narbo K., Sjostrom C.D., Karason K., Larsson B., Wedel H., et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357 (2007) 741-752
2. Adams T.D., Gress R.E., Smith S.C., Halverson R.C., Simper S.C., Rosamond W.D., et al. Long-term mortality after gastric bypass surgery. N Engl J Med 357 (2007) 753-761
3. Buchwald H., Avidor Y., Braunwald E., Jensen M.D., Prories W., Fahrbach K., et al. Bariatric surgery: systematic review and meta-analysis. JAMA 292 (2004) 1724-1737
4. Mingrone G., DeGaetano A., Greco A.V., Capristo E., Benedetti G., Castagneto M., et al. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia 40 (1997) 599-605
5. Laferrere B., Heshka S., Wang K., Khan Y., McGinty J., Teixeira J., et al. Incretin levels and effect are markedly enhanced one month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 30 (2007) 1709-1716
6. Swarbrick M.M., Austrheim-Smith T.A., Stanhope K.L., Van Loan M.D., Ali M.R., Wolfe B.M., et al. Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-en-Y gastric bypass surgery. Diabetologia 49 (2006) 2552-2558
7. Watanabe M., Houten S.M., Wang L., Moschetta A., Mangelsdorf D.J., Heyman R.A., et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest 113 (2004) 1408-1418
8. Watanabe M., Houten S.M., Mataki C., Christoffolete M.A., Kim B.W., Sato H., et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439 (2006) 484-489
9. Kasama K., Tagaya N., Kanahira E., Umezawa A., Kurosaki T., Oshiro T., et al. Has laparoscopic bariatric surgery been accepted in Japan? The experience of a single surgeon. Obes Surg 18 (2008) 1473-1478
10. Nakano Y., Tajima S., Yoshimi A., Akiyama H., Tsushima M., Tanioka T., et al. A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin. J Lipid Res 47 (2006) 1572-1582
11. Drucker J.D., and Nauck M.A. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368 (2006) 1696-1705
12. Guidone C., Manco M., Valera-Mora E., Iaconelli A., Gniuli D., Mari A., et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 55 (2006) 2025-2031
13. Verdich C., Toubro S., Buemann B., Madsen J.L., Holst J.J., and Astrup A. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety-effect of obesity and weight reduction. Int J Obes 25 (2001) 1206-1214
14. Laferrere B., Teixeira J., McGinty J., Tran H., Egger J.R., Colarusso A., et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 93 (2008) 2479-2485
15. Clements R.H., Gonzales Q.H., Long C.I., Wittert G., and Laws H.L. Hormonal changes after Roux-en-Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus. Am Surg 70 (2004) 1-4
16. Naslund E., Backman L., Holst J.J., Theodorsson E., and Hellstrom P.M. Importance of small bowel peptides for the improved glucose metabolism 20 years after jejuno-ileal bypass for obesity. Obes Surg 8 (1998) 253-260
17. Katsuma S., Hirasawa A., and Tsujimoto G. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 329 (2005) 386-390
18. Fonseca V.A., Rosenstock J., Wang A.C., Truitt K.E., and Jones M.R. Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy. Diabetes care 31 (2008) 1479-1484
19. Goldberg R.B., Fonseca V.A., Truitt K.E., and Hones M.R. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy. Arch Intern Med 168 (2008) 1531-1540
20. Everson G.T. Steady-state kinetics of serum bile acids in healthy human subjects: single and dual isotope techniques using stable isotopes and mass spectrometry. J Lipid Res 28 (1987) 238-252
21. Yamamoto Y., Hirose H., Saito I., Tomita M., Taniyama M., Matsubara K., et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci 103 (2002) 137-142
22. Weyer C., Funahashi I., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
23. Tschritter O., Fritsche A., Thamer C., Haap M., Shirkavand F., Rahe S., et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52 (2003) 239-243
24. Spranger J., Kroke A., Moehling M., Bergmann M.M., Ritow M., Boeling H., and Pfeiffer F.H. Adiponectin and protection against type 2 diabetes mellitus. Lancet 361 (2003) 226-228
25. Nakashima R., Kamei N., Yamane K., Nakanishi S., Nakashima A., and Kohno N. Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrin Metab 91 (2006) 3873-3877
26. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., and Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291 (2004) 1730-1737
27. Hara K., Horikoshi M., Yamauchi T., Yago H., Miyazaki O., Ebinuma H., et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 29 (2006) 1357-1362